Tci Wealth Advisors, Inc. Invitae Corp Transaction History

Tci Wealth Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$1.2 - $2.73 $2,224 - $5,061	-1,854 Reduced 77.64%	534 $0
Q4 2022 Feb 06, 2023	BUY	$1.71 - $3.61 $3,912 - $8,259	2,288 Added 2288.0%	2,388 $4,000
Q3 2022 Nov 08, 2022	SELL	$1.9 - $8.63 $3,442 - $15,637	-1,812 Reduced 94.77%	100 $0
Q2 2022 Jul 19, 2022	BUY	$2.13 - $9.01 $1,331 - $5,631	625 Added 48.56%	1,912 $5,000
Q1 2022 Apr 29, 2022	BUY	$6.28 - $15.59 $3,278 - $8,137	522 Added 68.24%	1,287 $10,000

Q4 2021 Jan 24, 2022	BUY	$14.7 - $28.67 $7,011 - $13,675	477 Added 165.63%	765 $12,000
Q3 2021 Oct 29, 2021	SELL	$24.31 - $33.6 $3,354 - $4,636	-138 Reduced 32.39%	288 $8,000
Q2 2021 Aug 02, 2021	BUY	$26.09 - $40.4 $2,556 - $3,959	98 Added 29.88%	426 $14,000
Q1 2021 Apr 29, 2021	BUY	$33.06 - $56.93 $10,843 - $18,673	328 New	328 $13,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.